- Home
- ASUR vs SLS Comparison
ASUR vs SLS Comparison
Compare ASUR & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASUR | SLS |
|---|---|---|
| Founded | 1985 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.9M | 208.0M |
| IPO Year | 1992 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASUR | SLS |
|---|---|---|
| Price | $8.92 | $2.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $13.60 | $7.00 |
| AVG Volume (30 Days) | 99.7K | ★ 4.5M |
| Earning Date | 10-30-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $132,022,000.00 | N/A |
| Revenue This Year | $19.20 | N/A |
| Revenue Next Year | $14.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.54 | N/A |
| 52 Week Low | $7.63 | $0.77 |
| 52 Week High | $12.74 | $2.48 |
Technical Indicators
Market Signals| Indicator | ASUR | SLS |
|---|---|---|
| Relative Strength Index (RSI) | 66.09 | 69.82 |
| Support Level | $8.62 | $1.92 |
| Resistance Level | $8.99 | $2.12 |
| Average True Range (ATR) | 0.25 | 0.15 |
| MACD | 0.11 | 0.07 |
| Stochastic Oscillator | 91.82 | 93.21 |
Price Performance
Historical ComparisonAbout ASUR Asure Software Inc
Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes. It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money, and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its HCM products majorly in the United States.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.